New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2013
15:32 EDTABBV, RHHBYAbbVie suspends Leukemia therapy trials. Bloomberg reports
AbbVie (ABBV) and its partner in the trials, Roche (RHHBY), have cancelled five studies on an experimental leukemia and lymphoma medicine after two patient deaths said an AbbVie spokesperson, adding that AbbVie and its partner, Roche Holding, suspended the dose-escalation portion of the studies to determine the amount of drug that is safest and most effective, reported Bloomberg Friday afternoon. Reference Link
News For ABBV;RHHBY From The Last 14 Days
Check below for free stories on ABBV;RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 25, 2014
09:19 EDTABBVAbbVie sees Q3 revenue growth in low to mid single digits, consensus $4.75B
Subscribe for More Information
09:17 EDTABBVAbbVie sees FY14 global Humira sales to see double digit growth
Subscribe for More Information
07:50 EDTABBVAbbVie reports Q2 Global HUMIRA sales up 26.2% to $3.29B
Total company sales growth was also driven by strong growth from key products including Synthroid, Sevoflurane and Duodopa.
07:48 EDTABBVAbbVie sees Q3 adjusted EPS 77c-79c, consensus 77c
07:48 EDTABBVAbbVie backs FY14 adjustd EPS $3.06-$3.16, consensus $3.14
Subscribe for More Information
07:47 EDTABBVAbbVie reports Q2 adjusted EPS 82c, consensus 76c
Subscribe for More Information
07:35 EDTRHHBYEMA recommends new indication for RoActemra in severe arthritis
Subscribe for More Information
07:31 EDTABBVEMA recommends expanded indication for Humira
Subscribe for More Information
July 24, 2014
12:56 EDTABBVPerrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0%
Subscribe for More Information
06:13 EDTRHHBYRoche reaffirms outlook for 2014
Subscribe for More Information
06:12 EDTRHHBYRoche reports 1H core EPS CHF 7.57 vs. CHF 7.58 last year
Subscribe for More Information
July 23, 2014
09:08 EDTRHHBYUltragenyx appoints Sunil Agarwal, M.D. as Chief Medical Officer
Subscribe for More Information
July 22, 2014
05:21 EDTRHHBYRoche announces Genentech Avastin granted priority review by FDA
Subscribe for More Information
July 21, 2014
10:27 EDTABBVUBS pharma and federal affairs analysts hold an analyst/industry conference call
Subscribe for More Information
08:01 EDTABBVAbbVie acquisition positive, says Argus
Subscribe for More Information
07:59 EDTABBVShire downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Shire (SHPG) on Friday to Market Perform citing the takeover by AbbVie (ABBV) as it does not expect competitive bids to emerge.
07:11 EDTRHHBYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
06:43 EDTRHHBY, ABBVGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
06:10 EDTABBVStocks with implied volatility movement; ABBV JOY
Subscribe for More Information
July 20, 2014
15:42 EDTRHHBYRoche not looking for big acquisitions, Reuters says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use